Enhancing Diagnostic Accuracy: High-Purity sCD14-ST Reagents for Advanced Immunoassays
Leveraging advanced chemiluminescence technology for precise infection and inflammation biomarker detection.
Get a Quote & SampleProduct Core Value
sCD14-ST Reagent
Our sCD14-ST reagent offers a novel approach to detecting infection and inflammation by directly measuring immune cell activation. This marker plays a crucial role in managing various critical conditions.
- Discover the clinical significance of sCD14-ST for diagnosing neonatal sepsis and assessing its severity, aiding in early intervention.
- Utilize sCD14-ST as a potential inflammation biomarker for the diagnosis and prognosis of Prosthetic Joint Infection (PJI), ensuring better patient outcomes.
- Benefit from sCD14-ST as an early diagnostic marker for Febrile Neutropenia (FN), even in cases with extremely low WBC counts, improving treatment decisions.
- Employ sCD14-ST for reliable bacterial infection identification and sepsis severity assessment, providing critical data for patient care.
Advantages of Using Our Reagents
High Specificity for Infection
sCD14-ST is mediated by pathogens, making it a direct infectious biomarker, crucial for differentiating between bacterial and non-bacterial causes of inflammation. This aids in targeted treatment strategies.
Early Detection Capabilities
This marker demonstrates its value in early detection, such as identifying Febrile Neutropenia (FN) prior to CRP elevation, allowing for prompt therapeutic actions to improve patient prognosis.
Reliable Monitoring Tool
sCD14-ST serves as a powerful monitoring tool for sepsis treatment, with levels showing significant changes correlating with patient recovery and treatment effectiveness.
Key Applications
Neonatal Sepsis
sCD14-ST is a valuable biomarker for neonate sepsis, playing an important role in the rapid assessment and evaluation of severity. Its levels can help identify infective vs. non-infective SIRS.
Prosthetic Joint Infection (PJI)
sCD14-ST shows promise for PJI diagnosis and prognosis, with levels significantly higher in patients and dropping with recovery, offering a reliable indicator.
Febrile Neutropenia (FN)
As an early diagnostic marker for FN in hematologic malignancy patients, sCD14-ST aids in timely intervention, even with low WBC counts.
Sepsis and Septic Shock
sCD14-ST is a sensitive biomarker for assessing sepsis severity and a predictive marker for adult sepsis, aiding in better patient management and treatment monitoring.